Transcranial Laser Therapy for Major Depressive Disorder

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Major Depressive Disorder
Interventions
DEVICE

Near-infrared radiation via Transcranial LED Therapy

"The subject will lie down comfortably on a exam bed . The sites of application of TLT (left and right forehead) will be inspected for any skin lesions (e.g. laceration or signs of inflammation) which would contraindicate the treatment. The subject will wear protective eyewear in the form of goggles or eye pads.~The staff administering the TLT will be careful not to shine the light in or near the eyes of the subject. The two OLS devices will be secured in position with the use of a Hair Net. The delivery of the TLT is expected to last 20 min total (simultaneous application on the left and right forehead). The subject will be asked to rest for five minutes after the delivery of TLT. The skin at the sites of the application will be inspected again prior to dismissing the subject."

DEVICE

Sham device

The sham device does not emit near-infrared radiation.

Trial Locations (2)

02114

Massachusetts General Hospital- Depression Clinical and Research Program, Boston

02150

Chelsea Counseling Center- North Suffolk Mental Health Association, Chelsea

All Listed Sponsors
collaborator

Mclean Hospital

OTHER

collaborator

North Suffolk Mental Health Association

OTHER

lead

Paolo Cassano

OTHER

NCT01538199 - Transcranial Laser Therapy for Major Depressive Disorder | Biotech Hunter | Biotech Hunter